Active surveillance in favorable intermediate-risk prostate cancer patients: Predictors of deferred intervention and treatment choice.

Active surveillance (AS) is increasingly used for favorable intermediate-risk (FIR) prostate cancer (PCa). Our objective was to determine oncological and sociodemographic predictors of deferred definitive therapy and decision for radical prostatectomy (RP) vs.